Previous 10 | Next 10 |
What do you think about when you encounter the phrase “swing trade.” Buy at the bottom of a stock’s trading range and then sell at the top. Yeah, right. Who doesn’t want to do that! Often, though, such aspirations translate to fanciful daydreaming, especially whe...
SAN CARLOS, Calif. , June 24, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced a nationwide registry study for kidney transplant recipients called ProActive. This is one of the largest known prospective studies to date, i...
SAN CARLOS, Calif. , June 3, 2019 /PRNewswire/ -- A new study demonstrates the ability of Natera's Signatera™ test to assess patient response to immunotherapy in the metastatic setting across multiple cancer types by detecting molecular traces of circulating tumor DNA (ctDNA) in th...
SAN CARLOS, Calif. , May 21, 2019 /PRNewswire/ -- Noridian, the Medicare Administrative Contractor (MAC) for California -based laboratories, has posted a favorable draft local coverage determination (LCD) for use of Natera 's Prospera™ test to assess active rejection in kidney ...
After the IPO, Guardant Health ( GH ) delivered 133% returns. As of May 14, 2019, it sells at 38x forward sales. Other peers are trading at cheaper valuations. The market expects additional revenue from the company’s new early detection program. It explains why the EV/Forward sales rati...
Natera, Inc. (NTRA) Q1 2019 Earnings Conference Call May 09, 2019 04:30 PM ET Company Participants Michael Brophy - Chief Financial Officer Paul Billings - Chief Medical Officer and Senior Vice President of Medical Affairs Solomon Moshkevich - General Manager of Oncology & Tr...
The following slide deck was published by Natera, Inc. in conjunction with their 2019 Q1 earnings Read more ...
Gainers: Charles & Colvard (NASDAQ: CTHR ) +34% . Buckeye Partners (NYSE: BPL ) +28% . Cardlytics (NASDAQ: CDLX ) +26% . G1 Therapeutics (NASDAQ: GTHX ) +24% . Westport Fuel Systems (NASDAQ: WPRT ) +21% . Cool Holdings (NASDAQ: AWSM ) +22% . Guardant Health (NASDAQ: GH ) +...
Natera (NASDAQ: NTRA ): Q1 GAAP EPS of -$0.54 beats by $0.06 . More news on: Natera, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
SAN CARLOS, Calif. , May 9, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today reported financial results for the first quarter ended March 31, 2019 and provided an update on rec...
News, Short Squeeze, Breakout and More Instantly...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will release results for its second quarter ended June 30, 2024, after the market close on Aug. 8, 2024. Natera will host a conference call and webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m. ET...
Study reports high accuracy of Signatera for surveillance of MCC patients, suggests potential to reduce frequency of surveillance imaging Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced a new study published in the Journal of Clinical Oncolog...
2024-07-23 12:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...